Avalo Therapeutics Inc (AVTX)
14.36
-1.03
(-6.69%)
USD |
NASDAQ |
May 03, 16:00
14.20
-0.16
(-1.11%)
Pre-Market: 20:00
Avalo Therapeutics Normalized Income (Quarterly)
Normalized Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Normalized Income (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -- |
September 30, 2023 | -- |
June 30, 2023 | -- |
March 31, 2023 | -- |
December 31, 2022 | -- |
September 30, 2022 | -- |
June 30, 2022 | -- |
March 31, 2022 | -- |
December 31, 2021 | -- |
September 30, 2021 | -- |
June 30, 2021 | -- |
March 31, 2021 | -- |
December 31, 2020 | -- |
September 30, 2020 | -- |
June 30, 2020 | -- |
March 31, 2020 | -- |
December 31, 2019 | -- |
September 30, 2019 | -- |
June 30, 2019 | -- |
March 31, 2019 | -- |
Date | Value |
---|---|
December 31, 2018 | -- |
September 30, 2018 | -- |
June 30, 2018 | -- |
March 31, 2018 | -- |
December 31, 2017 | -- |
September 30, 2017 | -- |
June 30, 2017 | -- |
March 31, 2017 | -- |
December 31, 2016 | -- |
September 30, 2016 | -- |
June 30, 2016 | -- |
March 31, 2016 | -- |
December 31, 2015 | -- |
September 30, 2015 | -- |
June 30, 2015 | -- |
March 31, 2015 | -- |
December 31, 2014 | -- |
September 30, 2014 | -- |
June 30, 2014 | -- |
March 31, 2014 | -- |
Normalized Income Definition
Normalized Income is the company's income after removing expenses and revenue that are not recurring. Normalized income gives investors a better idea of the company's income in a "normal" year.